Bio-Techne (TECH) Change in Inventory (2009 - 2026)
Bio-Techne (TECH) posted quarterly Change in Inventory of -$3.4 million for Q1 2026, down 1883.24% year-over-year from $192402.9 in Q1 2025, and down 276.95% quarter-over-quarter from $1.9 million in Q4 2025.
Analysis
Bio-Techne (TECH) Change in Inventory (2009 - 2026) Analysis & Trends
Bio-Techne's Change in Inventory history runs 18 years deep, the most recent figure standing at -$3.4 million for Q1 2026.
- In Q1 2026, Change in Inventory fell 1883.24% year-over-year to -$3.4 million; the TTM figure through Mar 2026 stood at $19.1 million (up 18.31% YoY), while the FY2025 annual figure was $18.1 million, up 27.64% from the prior year.
- Change in Inventory for Q1 2026 stood at -$3.4 million, down from $1.9 million in the prior quarter.
- The five-year high for Change in Inventory was $16.0 million in Q2 2022, with the low at -$3.4 million in Q1 2026.
- The 5-year median for Change in Inventory is $5.2 million (2023), against an average of $5.8 million.
- The sharpest annual moves came in 2022 and 2026: Change in Inventory surged 428.03% in 2022, then tumbled 1883.24% in 2026.
- Bio-Techne's Change in Inventory stood at $7.7 million in 2022, then tumbled by 43.19% to $4.4 million in 2023, then surged by 104.27% to $8.9 million in 2024, then slumped by 78.23% to $1.9 million in 2025, then plunged by 276.95% to -$3.4 million in 2026.
- Business Quant data shows TECH's Change in Inventory at -$3.4 million in Q1 2026, $1.9 million in Q4 2025, and $14.0 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 132.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 47.15 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -280,000.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Bio-Techne | 11.29 Bn | 11.03 Bn | 211.39 Mn | -4.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4.28 Mn |
| Mar 31, 2026 | -3.43 Mn |
| Dec 31, 2025 | 1.94 Mn |
| Sep 30, 2025 | 14.00 Mn |
| Jun 30, 2025 | 6.60 Mn |
| Mar 31, 2025 | -173,000.00 |
| Dec 31, 2024 | 8.91 Mn |
| Sep 30, 2024 | 2.81 Mn |
| Jun 30, 2024 | 4.62 Mn |
| Mar 31, 2024 | 22,000.00 |
| Dec 31, 2023 | 4.36 Mn |
| Sep 30, 2023 | 5.22 Mn |
| Jun 30, 2023 | 1.35 Mn |
| Mar 31, 2023 | 10.45 Mn |
| Dec 31, 2022 | 7.68 Mn |
| Sep 30, 2022 | 10.69 Mn |
| Jun 30, 2022 | 15.97 Mn |
| Mar 31, 2022 | 7.33 Mn |
| Dec 31, 2021 | 5.72 Mn |
| Sep 30, 2021 | 2.98 Mn |